Cargando…
Novel monoclonal antibody against beta 1 integrin enhances cisplatin efficacy in human lung adenocarcinoma cells
The use of anti-beta 1 integrin monoclonal antibody in lung cancer treatment has proven beneficial. Here, we developed a novel monoclonal antibody (mAb), called P5, by immunizing mice with human peripheral blood mononuclear cells (PBMC). Its anti-tumor effect is now being tested, in a clinical phase...
Autores principales: | Kim, Min-Young, Cho, Woon-Dong, Hong, Kwon Pyo, Choi, Da Bin, Hong, Jeong won, Kim, Soseul, Moon, Yoo Ri, Son, Seung-Myoung, Lee, Ok-Jun, Lee, Ho-Chang, Song, Hyung Geun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885170/ https://www.ncbi.nlm.nih.gov/pubmed/27533932 http://dx.doi.org/10.7555/JBR.30.2016K0005 |
Ejemplares similares
-
CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas
por: Lee, Ok-Jun, et al.
Publicado: (2014) -
Characterization of Two Novel mAbs Recognizing Different Epitopes on CD43
por: Kim, Soseul, et al.
Publicado: (2014) -
Characterization of a Novel Monoclonal Antibody (27H2) Recognizing Human CD34 Class III Epitope
por: Hong, Kwon Pyo, et al.
Publicado: (2010) -
Generation of 1E8 Single Chain Fv-Fc Construct Against Human CD59
por: Hong, Jeong-Won, et al.
Publicado: (2012) -
Fine Needle Aspiration Cytology of Metastatic Adenocarcinoma of the Gingiva from the Lung: A Case Report
por: You, Tack Kune, et al.
Publicado: (2012)